University Hospital Zürich
Zurich, Canton of Zurich, 8091, Switzerland
NCT Number: NCT06385301
The investigators aim to study the effect of SOT in subjects with chronic lung disease in submaximal exercise.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Zurich, Canton of Zurich, 8091, Switzerland
Participants with lung disease who live in Switzerland will have 6-minute walk distance (6MWD) test with and without SOT at approximately 3l/min via nasal cannula according to a randomized cross-over design.
The trial aims to test that the 6MWD with SOT is non-inferior to a 6MWD in the same participant under ambient air.
Our effect size was estimated with a difference of less or equal to 35m compared under SOT compared to ambient air.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
6-minute walk distance (6MWD) test will be performed on ambient air according to clinical standards
6-minute walk distance (6MWD) test will be performed according to clinical standards additionally with supplemental oxygen therapy (approximately 3l/min, nasal)
Time frame: after 6 minutes
Change in 6MWD in meter between SOT via nasal cannula vs. ambient air
Time frame: after 6 minutes
Change of the arterial oxygen saturation by pulse oximetry (SpO2) at rest and at peak 6MWD with SOT vs. ambient air
Time frame: after 6 minutes
Change of heart rate (bpm) at rest and at peak 6MWD with SOT vs. ambient air
Time frame: 6 minutes
Change of Borg dyspnea scale at rest and at peak 6MWD with SOT vs. ambient air
Time frame: after 6 minutes
Change of Borg leg fatigue scale at rest and at peak 6MWD with SOT vs. ambient air
Time frame: after 6 minutes
Change of Blood pressure (mmHg) at rest and at peak 6MWD with SOT vs. ambient air
University of Zurich
Other
Exercise Performance on Ambient Air vs. Commonly Prescribed Nasal Low Oxygen Therapy - a Non-Inferiority Trial in Patients With Exercise Induced Desaturation Due to Chronic Lung Diseases
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06149494
COPD, COPD Exacerbation Acute
London, United Kingdom
View Trial DetailsNCT03746392
Brain Diseases, Cardiovascular Diseases
Seattle, Washington, United States
View Trial DetailsNCT05771766
Lung Disease Chronic
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT03790644
Lung Disease Chronic
Toronto, Ontario, Canada
View Trial Details